Beat Mullhaupt

Head of Hepatology

University Hospital

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Beat Mullhaupt is the Head of Hepatology at University Hospital in Switzerland. His research focuses on chronic hepatitis C treatment, cardio-hepatic interactions, and the clinical characteristics of alveolar echinococcosis. Recent publications include studies on the effects of hepatitis C cure on the gut microbiome and the evaluation of treatment strategies for complex liver conditions.

Articles (7)

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Hermann Einsele

University Hospital Würzburg

GERMANY

View details

Maksym Bondarenko

University of Southampton

UNITED KINGDOM

View details

Stefan Störk

University Hospital Würzburg

GERMANY

View details

Torben Schubert

Deputy Head

Fraunhofer Institute for Systems and Innovation Research

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Beat Mullhaupt

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis

Cardio-Hepatic Interaction in Cardiac Amyloidosis

Characteristics and Clinical Course of Alveolar Echinococcosis in Patients with Immunosuppression-Associated Conditions: A Retrospective Cohort Study

Evaluation of a structured treatment discontinuation in patients with inoperable alveolar echinococcosis on long-term benzimidazole therapy: A retrospective cohort study

Association between environmental and climatic risk factors and the spatial distribution of cystic and alveolar echinococcosis in Kyrgyzstan

Pilot Sub-Study of the Effect of Hepatitis C Cure by Glecaprevir/Pibrentasvir on the Gut Microbiome of Patients with Chronic Hepatitis C Genotypes 1 to 6 in the Mythen Study

The 13 C‐methactin breath test is non‐inferior to liver biopsy in predicting liver‐related death and transplantation: A 7‐year prospective follow‐up study in 132 patients with chronic hepatitis C infection

Collaborators (4)

Hermann Einsele

Maksym Bondarenko

Stefan Störk

Torben Schubert

Make your next move.